Eton Pharmaceuticals and Aquestive Therapeutics sign exclusive US license and supply agreement for LIBERVANT buccal film

Eton Pharmaceuticals and Aquestive Therapeutics entered an exclusive US license and supply agreement for LIBERVANT buccal film, used for seizure clusters in epilepsy patients. Commercial availability is expected in April 2027.

Detected & updated continuously · Source: Nebula